labs

Latest stories

  • in Health care

    Dr Reddys Labs unveils Treprostinil Injection in US

    by

    Hyderabad: Dr. Reddy’s Laboratories Ltd. has announced the launch of Treprostinil Injection in the U.S. market, a therapeutic equivalent generic version of Remodulin (treprostinil) Injection, approved by U. S. Food and Drug Administration (USFDA).  Treprostinil injection is a prostacyclin mimetic indicated for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) to diminish symptoms associated […] More

  • 12 Views

    in Health care

    Dr Reddy’s Labs names Sonu Sood as brand ambassador for Rebalanz Vitors

    by

    Hyderabad: Dr. Reddy’s Laboratories Limited on Tuesday announced that it has roped in fitness enthusiast, actor and philanthropist, Sonu Sood as its brand ambassador for Rebalanz Vitors. Launched in 2018, Rebalanz Vitors has grown rapidly to occupy a significant market position in the Ready-to- Serve fruit beverage segment, amongst existing and new players, Hyderabad-based Pharmaceutical […] More

  • in Health care

    Dr Reddys Labs concludes acquisition of Mayne Pharma’s US generic prescription product portfolio

    Dr Reddys Labs concludes acquisition of Mayne Pharma's US generic prescription product portfolio

    by

    Hyderabad: Pharma major, Dr Reddys Labs, has recently announced that the company has completed the acquisition of Mayne Pharma’s U.S. generic prescription product portfolio. The portfolio includes approximately 45 commercial products, four pipeline products and 40 approved non-marketed products, including a number of generic products focused on women’s health. For the financial period ended June […] More

  • in Health care

    Alkem Labs Ankleshwar facility clears USFDA inspection

    Alkem Labs Ankleshwar facility clears USFDA inspection

    by

    Mumbai: Through a recent BSE filing, Alkem Labs has informed that the company’s API manufacturing facility located at Ankleshwar, Gujarat has cleared the United States Food and Drug Administration (US FDA) inspection. The inspection was held from 03rd April, 2023 to 07th April, 2023. “This is to inform you that US FDA had conducted a GMP […] More

  • in Health care

    Submit revised BE study protocol: CDSCO panel tells Laurus Labs on Carglumic Acid Dispersible Tablets

    by

    New Delhi: Rejecting drug maker Laurus Lab’s proposal for clinical trial waiver of Carglumic acid dispersible tablets 200mg, the subject committee expert (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has opined the firm to submit a revised bioequivalence (BE) study protocol by capturing complete details such as the objective of the study, […] More